MGC Pharmaceuticals has signed a deal to distribute cannabis-based pharmaceutical products throughout Europe and to produce and cultivate medical cannabis in Malta.
The Australian company made the distribution agreement with AM Mangion, a Maltese company specialising in the distribution of products in the medical sector.
MGC will supply an “initial range” of products which AM Mangion will distribute through Malta, Italy, France, Spain, Portugal and the UK – and also in the Middle East and North Africa.
Other products will be included for distribution on an agreed ad hoc basis, MGC said.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us